More on ALMDT
News
- Median Technologies and Olea Medical, a Canon Medical Systems Company, Partner to Advance Commercial Deployment of AI-Powered eyonis® LCS for Lung Cancer Screening
- Median Technologies Reports Record iCRO Backlog, Accelerates Commercial Rollout of eyonis® LCS and Development of New Indications Across the eyonis® Portfolio
- Half Year Median Technologies Liquidity Contract Statement
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of June 30, 2026
- Median Technologies’ eyonis® LCS Obtains CE Marking
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of May 31, 2026
- Median Technologies Launches a Capital Increase of €40 million, with Potential Upsize to €50 million, to Support the Deployment of eyonis® LCS in the U.S. and Europe and Advance New Clinical Indi
- Median Technologies to Showcase iCRO’s Central and AI-powered Imaging Services for Oncology Clinical Trials at ASCO 2026
- Median Technologies Announces the Availability of the Preparatory Documents for the Annual Shareholders’ Ordinary and Extraordinary General Meeting on June 10, 2026
- Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of April 30, 2026
Entities mentioned with ALMDT
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Cowen & Co | View Related Stories »
- Definitive Agreement | View Related Stories »
- Dividend | View Related Stories »
- Carl Icahn | View Related Stories »
- IPO | View Related Stories »
- Elliott Associates | View Related Stories »
- Show More...
